US Federal 2025-2026 Regular Session

US Federal House Bill HB5629

Introduced
9/30/25  

Caption

To provide that the final rule of the Department of Health and Human Services titled "Medications for the Treatment of Opioid Use Disorder", except for the portion of the final rule relating to accreditation of opioid treatment programs, shall have no force or effect.

Companion Bills

No companion bills found.

Previously Filed As

US SB2505

Relating To Opioid Use Disorder Treatment.

US H681

Update Opioid Abatement Treatment Prog. Rules

US HB2063

Relating To Opioid Use Disorder Treatment.

US H1379

Exempting medications used for the treatment of opioid use disorder from the prior approval process under the Massachusetts Medicaid program

US H824

Expand Treatment Access/Opioid Use Disorder

US HB718

Opioid use disorder; require substance use disorder facilities to provide pregnant women with onsite access to certain treatments.

US S0143

Establishes a program within the adult correctional institution to permit medication assisted treatment approved by the FDA to be provided for the treatment of opioid use disorder to any incarcerated individual.

US S2049

Establishes a program within the adult correctional institution to permit medication assisted treatment approved by the FDA to be provided for the treatment of opioid use disorder to any incarcerated individual.

US H4014

Authorizing pharmacists to provide opioid use disorder treatment

US S1635

Authorizing pharmacists to provide opioid use disorder treatment

Similar Bills

No similar bills found.